{"componentChunkName":"component---src-templates-topic-topic-tsx","path":"/topics/palliative-care-nausea-vomiting/","result":{"data":{"firstChapter":{"id":"4cf6ed2e-fa29-54e9-8d93-4bd52407c5c4","slug":"summary","fullItemName":"Summary","subChapters":[],"depth":1,"htmlHeader":"<!-- begin field bde77f9f-de64-4aa5-8f97-6dcda6bb3114 --><h1>Palliative care - nausea and vomiting: Summary</h1><!-- end field bde77f9f-de64-4aa5-8f97-6dcda6bb3114 -->","htmlStringContent":"<!-- begin item 2335cfbc-f754-4370-8d89-8d66cd01570d --><!-- begin field 103fd30d-28bd-482b-9f8c-888c7fb92d59 --><ul><li>Nausea is an unpleasant sensation of the need to vomit, which is often accompanied by autonomic symptoms (for example pallor, cold sweat, salivation, and tachycardia).</li><li>Vomiting (emesis) is the forceful ejection of stomach contents through the mouth.</li><li>There are many causes of nausea and vomiting in the palliative care setting, including:<ul><li>Drugs (for example opioids and cytotoxic drugs).</li><li>Metabolic causes (for example from hypercalcaemia or renal failure).</li><li>Gastric stasis (due to drugs, ascites, hepatomegaly, peptic ulcer, or gastritis).</li><li>Vestibular disturbance (from opioids or cerebral metastases)</li><li>Anxiety (for example before chemotherapy).</li></ul></li><li>Nausea and vomiting may cause various complications, including dehydration and electrolyte imbalance, decreased nutrition, and decreased quality of life.</li><li>When assessing a person to determine the cause of nausea and vomiting:<ul><li>Findings from their history, examination, and investigations should be reviewed to try to identify the cause of the nausea and vomiting, and assess the person's clinical state. If appropriate, blood tests should be considered to exclude hypercalcaemia or renal failure.</li><li>A decision should be made on whether to treat the cause of nausea and vomiting, or whether the emphasis should be on the treatment of symptoms.</li><li>Several factors may determine this decision. These include the stage of the person’s illness, their prognosis, the severity of their symptoms, and the wishes of the person and their family. </li></ul></li><li>Simple measures may help relieve nausea and vomiting in palliative care. They include:<ul><li>Ensuring access to a large bowl, tissues, and water.</li><li>Eating snacks consisting of a few mouthfuls rather than large meals.</li><li>Drinking cool fizzy drinks rather than still or hot drinks.</li><li>Relaxation techniques. </li><li>Parenteral hydration, if appropriate. </li><li>Cognitive behavioural therapy (for anticipatory nausea or vomiting).</li></ul></li><li>The underlying cause of nausea and vomiting should be managed, if possible and appropriate. Anti-emetics should be chosen according to the cause, if known. For example:<ul><li>For chemically and metabolically-induced nausea and vomiting, haloperidol should be used.</li><li>For gastric stasis, metoclopramide should be used.</li><li>For movement-related nausea and vomiting, cyclizine should be used.</li><li>For anxiety related nausea and vomiting, a benzodiazepine should be considered.</li></ul></li><li>Anti-emetics should be:<ul><li>Given via the most appropriate route.</li><li>Prescribed regularly and as required.</li><li>Reviewed every 24 hours.</li><li>Continued unless symptoms have resolved.</li></ul></li><li>If a single first-line anti-emetic does not relieve nausea and vomiting:<ul><li>The cause of nausea and vomiting should be re-assessed.</li><li>The anti-emetic dose should be optimized and/or the route of administration re-assessed.</li><li>If symptoms persist after 2 or 3 doses of optimal first-line anti-emetic, a different anti-emetic or a combination of anti-emetics with complementary action should be tried.</li><li>If symptoms still persist after 24 hours, the person should be referred to a specialist palliative care team.</li></ul></li><li>If the cause is uncertain, or further investigation is not appropriate:<ul><li>Haloperidol should be tried. Cyclizine should be added if haloperidol is ineffective.</li><li>If symptoms persist, levomepromazine or dexamethasone can be considered after seeking specialist advice.</li></ul></li></ul><!-- end field 103fd30d-28bd-482b-9f8c-888c7fb92d59 --><!-- end item 2335cfbc-f754-4370-8d89-8d66cd01570d -->","topic":{"id":"8a2e6dd8-7d6f-5fcf-a744-1b12e2a14232","topicId":"329a162f-132a-4d7e-afd5-7ff2f86369d2","topicName":"Palliative care - nausea and vomiting","slug":"palliative-care-nausea-vomiting","aliases":[],"chapters":[{"id":"4cf6ed2e-fa29-54e9-8d93-4bd52407c5c4","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"2e3a3e75-af78-5547-a042-7aa68a341672","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"27d24f4a-dbc8-560f-b100-ca5287022d66","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"b433057a-92f0-5457-837c-f3f7235e44e6","slug":"changes","fullItemName":"Changes"},{"id":"540b41fe-3e71-5c29-9379-7493711a8a59","slug":"update","fullItemName":"Update"}]},{"id":"ed201382-7c29-58e9-ba5d-f5c415eb3bf3","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"7043600f-13dd-5980-b06d-73dab2266896","slug":"goals","fullItemName":"Goals"},{"id":"63b87fa3-3c3d-527b-9ac2-e856dd0c559e","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"6e3ee330-3c0d-5735-b8d5-76b606865d07","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"d1227949-2a90-5b29-abef-3895e05333c3","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"e2e036e5-217a-593d-947f-a8376f0f5e98","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"3885ba7b-9d6f-5262-a541-463284363660","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"b65bec71-2fa0-54e0-be57-13a917c2a697","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"a9561403-d5a9-5c9c-b6e6-c24410e9d9d3","slug":"definition","fullItemName":"Definition"},{"id":"d92b4aee-031c-58a4-b4b9-5d13767e0261","slug":"prevalence","fullItemName":"Prevalence"},{"id":"b1327253-7b93-5a44-b2f7-5e002ae90e8f","slug":"causes","fullItemName":"Causes"},{"id":"e321f36e-5ec2-5074-b128-109efef69a65","slug":"complications","fullItemName":"Complications"}]},{"id":"a4a81f08-7894-5ba4-a4e5-c5505f3e5250","slug":"management","fullItemName":"Management","subChapters":[{"id":"8691c12d-3ed6-5e16-bef3-667d198f6707","slug":"assessment","fullItemName":"Scenario: Assessment"},{"id":"e2566bf0-9d82-5bc7-9b5f-835384f56bc2","slug":"known-cause","fullItemName":"Scenario: Known cause"},{"id":"c8237819-4755-5cd8-ad7c-12735068c87a","slug":"unknown-cause","fullItemName":"Scenario: Unknown cause"},{"id":"145fe4aa-682c-5299-9906-a7bca2e98a9b","slug":"end-of-life","fullItemName":"Scenario: End of life"}]},{"id":"4d9745dc-8b36-500d-8e94-0e51611a4373","slug":"prescribing-information","fullItemName":"Prescribing information","subChapters":[{"id":"f61e929d-def9-58db-877e-a030bc91d3de","slug":"prescribing-an-anti-emetic","fullItemName":"Prescribing an anti-emetic"},{"id":"d39c4487-f9dc-5d1d-be98-95561ca991bd","slug":"prescribing-a-prokinetic","fullItemName":"Prescribing a prokinetic"},{"id":"23e74db2-9671-539b-8bcf-b5c4bdff23f9","slug":"prescribing-haloperidol","fullItemName":"Prescribing haloperidol"},{"id":"00a2a0a3-8bc1-5d27-a03f-6cd4624d1c38","slug":"prescribing-levomepromazine","fullItemName":"Prescribing levomepromazine"},{"id":"d0437d3a-566f-5df2-9800-1961ed4664e8","slug":"prescribing-cyclizine","fullItemName":"Prescribing cyclizine"},{"id":"e6d5c2a8-e2b8-55c5-afd4-46f2edcd4a30","slug":"prescribing-dexamethasone","fullItemName":"Prescribing dexamethasone"},{"id":"3042d096-a74b-5c66-8d18-8c233091e783","slug":"prescribing-hyoscine-butylbromide","fullItemName":"Prescribing hyoscine butylbromide"}]},{"id":"ba414d8a-38a1-5962-84ab-6051ffe6dfe9","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"26e42d0a-9ee9-50c5-9f2b-818da289f6e9","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"c0795c41-1865-5ab1-b820-e41b8b5d9aab","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"3076afc1-a703-524e-9ec9-995b34c4d386","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"08b8fc57-db22-518d-a528-777cb4e8d7dc","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"81928ac1-4f26-5da9-b11f-85d1cee4fbdd","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"5aee10d5-2771-547a-a52a-1fb430319da3","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"3cfa53b2-3d63-508d-80ea-c2a6293844fc","slug":"references","fullItemName":"References","subChapters":[]}]}},"topic":{"id":"8a2e6dd8-7d6f-5fcf-a744-1b12e2a14232","topicId":"329a162f-132a-4d7e-afd5-7ff2f86369d2","topicName":"Palliative care - nausea and vomiting","slug":"palliative-care-nausea-vomiting","aliases":[],"topicSummary":"Nausea is an unpleasant sensation of the need to vomit, which is often accompanied by autonomic symptoms, for example pallor, cold sweat, salivation","lastRevised":"Last revised in October 2020","nextPlannedReviewBy":"2021-10-01T00:00:00+01:00","nextPlannedReviewByDateTime":"2021-09","nextPlannedReviewByDisplay":"September 2021","specialities":[{"id":"e4fd15e3-ef70-523f-843c-5270742f518d","name":"Gastrointestinal","slug":"gastrointestinal"},{"id":"ad789c56-a29e-5319-92cd-223890d75f09","name":"Palliative care","slug":"palliative-care"}],"chapters":[{"id":"4cf6ed2e-fa29-54e9-8d93-4bd52407c5c4","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"2e3a3e75-af78-5547-a042-7aa68a341672","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"27d24f4a-dbc8-560f-b100-ca5287022d66","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"b433057a-92f0-5457-837c-f3f7235e44e6","slug":"changes","fullItemName":"Changes"},{"id":"540b41fe-3e71-5c29-9379-7493711a8a59","slug":"update","fullItemName":"Update"}]},{"id":"ed201382-7c29-58e9-ba5d-f5c415eb3bf3","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"7043600f-13dd-5980-b06d-73dab2266896","slug":"goals","fullItemName":"Goals"},{"id":"63b87fa3-3c3d-527b-9ac2-e856dd0c559e","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"6e3ee330-3c0d-5735-b8d5-76b606865d07","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"d1227949-2a90-5b29-abef-3895e05333c3","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"e2e036e5-217a-593d-947f-a8376f0f5e98","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"3885ba7b-9d6f-5262-a541-463284363660","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"b65bec71-2fa0-54e0-be57-13a917c2a697","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"a9561403-d5a9-5c9c-b6e6-c24410e9d9d3","slug":"definition","fullItemName":"Definition"},{"id":"d92b4aee-031c-58a4-b4b9-5d13767e0261","slug":"prevalence","fullItemName":"Prevalence"},{"id":"b1327253-7b93-5a44-b2f7-5e002ae90e8f","slug":"causes","fullItemName":"Causes"},{"id":"e321f36e-5ec2-5074-b128-109efef69a65","slug":"complications","fullItemName":"Complications"}]},{"id":"a4a81f08-7894-5ba4-a4e5-c5505f3e5250","slug":"management","fullItemName":"Management","subChapters":[{"id":"8691c12d-3ed6-5e16-bef3-667d198f6707","slug":"assessment","fullItemName":"Scenario: Assessment"},{"id":"e2566bf0-9d82-5bc7-9b5f-835384f56bc2","slug":"known-cause","fullItemName":"Scenario: Known cause"},{"id":"c8237819-4755-5cd8-ad7c-12735068c87a","slug":"unknown-cause","fullItemName":"Scenario: Unknown cause"},{"id":"145fe4aa-682c-5299-9906-a7bca2e98a9b","slug":"end-of-life","fullItemName":"Scenario: End of life"}]},{"id":"4d9745dc-8b36-500d-8e94-0e51611a4373","slug":"prescribing-information","fullItemName":"Prescribing information","subChapters":[{"id":"f61e929d-def9-58db-877e-a030bc91d3de","slug":"prescribing-an-anti-emetic","fullItemName":"Prescribing an anti-emetic"},{"id":"d39c4487-f9dc-5d1d-be98-95561ca991bd","slug":"prescribing-a-prokinetic","fullItemName":"Prescribing a prokinetic"},{"id":"23e74db2-9671-539b-8bcf-b5c4bdff23f9","slug":"prescribing-haloperidol","fullItemName":"Prescribing haloperidol"},{"id":"00a2a0a3-8bc1-5d27-a03f-6cd4624d1c38","slug":"prescribing-levomepromazine","fullItemName":"Prescribing levomepromazine"},{"id":"d0437d3a-566f-5df2-9800-1961ed4664e8","slug":"prescribing-cyclizine","fullItemName":"Prescribing cyclizine"},{"id":"e6d5c2a8-e2b8-55c5-afd4-46f2edcd4a30","slug":"prescribing-dexamethasone","fullItemName":"Prescribing dexamethasone"},{"id":"3042d096-a74b-5c66-8d18-8c233091e783","slug":"prescribing-hyoscine-butylbromide","fullItemName":"Prescribing hyoscine butylbromide"}]},{"id":"ba414d8a-38a1-5962-84ab-6051ffe6dfe9","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"26e42d0a-9ee9-50c5-9f2b-818da289f6e9","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"c0795c41-1865-5ab1-b820-e41b8b5d9aab","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"3076afc1-a703-524e-9ec9-995b34c4d386","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"08b8fc57-db22-518d-a528-777cb4e8d7dc","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"81928ac1-4f26-5da9-b11f-85d1cee4fbdd","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"5aee10d5-2771-547a-a52a-1fb430319da3","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"3cfa53b2-3d63-508d-80ea-c2a6293844fc","slug":"references","fullItemName":"References","subChapters":[]}]}},"pageContext":{"id":"8a2e6dd8-7d6f-5fcf-a744-1b12e2a14232"}},"staticQueryHashes":["3666801979"]}